The Korean Journal of Internal Medicine10.3904/kjim.2013.28.4.4202013284420The dose of cyclophosphamide for treating paraquat-induced rat lung injuryJae-Sung Choi, Sung-Shick Jou, Mee-Hye Oh, Young-Hee Kim, Min-Ju Park, Hyo-Wook Gil, Ho-Yeon Song, Sae-Yong Hong,,
Toxicology Letters10.1016/j.toxlet.2010.03.8222010196S246Alterations of lung tissue and serum cytokines in a rat model of paraquat-induced lung injuryA. Zira, C. Giaginis, C. Maravelias, C. Spiliopoulou, S. Theocharis.,
Lung10.1007/bf027138411983161147-55Role of alveolar macrophages in development of paraquat-induced lung injuryT. Etoh, S. Shioya, Y. Ohta, H. Yamabayashi, J. Hata,,
Lung Cancer10.1016/s0169-5002(85)80185-9198511-239Radiation-induced lung fibrosis after treatment of small cell carcinoma of the lung with high-dose cyclophosphamide,
The Korean Journal of Internal Medicine10.3904/kjim.2017.33420183361137-1142Prolonged low-dose cyclophosphamide treatment after pulse therapy attenuates lung injury in rats with paraquat intoxicationJie Gao, Shunyi Feng, Yong Li,,
Journal of Gastrointestinal Surgery10.1007/s11605-009-0945-020091391683-1691Methylene Blue Attenuates Pancreas Ischemia–Reperfusion (IR)-Induced Lung Injury: A Dose Response Study in a Rat ModelAvi A. Weinbroum,,
Lung Cancer10.1016/s0169-5002(86)80100-3198623226High-dose cyclophosphamide in small-cell carcinoma of the lung,
Lung Cancer10.1016/s0169-5002(86)80531-1198621-2141Very high dose cyclophosphamide in treatment of small cell lung cancer (SCLC),
Lung Cancer10.1016/s0169-5002(86)80533-5198621-2142High-dose cyclophosphamide (HDC) and high-dose etoposide (HDE) with autologous bone marrow transplantation (ABMT) for recurrent or progressive small cell lung cancer (SCLC),
Lung Cancer10.1016/0169-5002(90)90366-t199061-260-61Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: A randomized trial of the Bristol Lung Cancer Study Group,